American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 12(63), 2019
DOI: 10.1128/aac.01225-19
Full text: Unavailable
The U.S. Centers for Disease Control and Prevention (CDC) lists Neisseria gonorrhoeae as one of the most urgent antibiotic-resistant threats in the United States. This is due to the emergence of clinical isolates that have developed resistance to nearly every antibiotic used to treat gonorrhea and highlights the critical need to find new therapeutics.